Selected research
Industry Research
Epirubicin Hydrochloride Industry Research Report 2026
Market perspective
The global Epirubicin Hydrochloride market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Epirubicin Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Epirubicin Hydrochloride is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Epirubicin Hydrochloride is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Epirubicin Hydrochloride include Flavine, Humble Healthcaare, Intas Pharma, Microbiopharm Japan, Sterling Biotech, Synbias Pharma, Teva API, Beijing Union Pharmaceutical Factory and DZD Heze Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Epirubicin Hydrochloride market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Epirubicin Hydrochloride Market by Company
Flavine
Humble Healthcaare
Intas Pharma
Microbiopharm Japan
Sterling Biotech
Synbias Pharma
Teva API
Beijing Union Pharmaceutical Factory
DZD Heze Pharma
Pfizer
Lunan Pharmaceutical Group
Zhejiang Hisun Pharma
Epirubicin Hydrochloride Segment by Type
10mg/5ml
50mg/25ml
Other
Epirubicin Hydrochloride Segment by Application
Cancer
Others
Epirubicin Hydrochloride Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epirubicin Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epirubicin Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epirubicin Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Epirubicin Hydrochloride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Epirubicin Hydrochloride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Epirubicin Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg/5ml
- 50mg/25ml
- Other
Applications
- Cancer
- Others
Companies covered
- Flavine
- Humble Healthcaare
- Intas Pharma
- Microbiopharm Japan
- Sterling Biotech
- Synbias Pharma
- Teva API
- Beijing Union Pharmaceutical Factory
- DZD Heze Pharma
- Pfizer
- Lunan Pharmaceutical Group
- Zhejiang Hisun Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Epirubicin Hydrochloride Market Size (2021-2032)
- 2.2.2 Global Epirubicin Hydrochloride Sales (2021-2032)
- 2.2.3 Global Epirubicin Hydrochloride Market Average Price (2021-2032)
- 2.3 Epirubicin Hydrochloride by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10mg/5ml
- 2.3.3 50mg/25ml
- 2.3.4 Other
- 2.4 Epirubicin Hydrochloride by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cancer
- 2.4.3 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Epirubicin Hydrochloride Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Epirubicin Hydrochloride Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Epirubicin Hydrochloride Revenue of Manufacturers (2021-2026)
- 3.4 Global Epirubicin Hydrochloride Average Price by Manufacturers (2021-2026)
- 3.5 Global Epirubicin Hydrochloride Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Epirubicin Hydrochloride, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Epirubicin Hydrochloride, Product Type & Application
- 3.8 Global Manufacturers of Epirubicin Hydrochloride, Established Date
- 3.9 Global Epirubicin Hydrochloride Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Flavine
- 4.1.1 Flavine Company Information
- 4.1.2 Flavine Business Overview
- 4.1.3 Flavine Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Flavine Epirubicin Hydrochloride Product Portfolio
- 4.1.5 Flavine Recent Developments
- 4.2 Humble Healthcaare
- 4.2.1 Humble Healthcaare Company Information
- 4.2.2 Humble Healthcaare Business Overview
- 4.2.3 Humble Healthcaare Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Humble Healthcaare Epirubicin Hydrochloride Product Portfolio
- 4.2.5 Humble Healthcaare Recent Developments
- 4.3 Intas Pharma
- 4.3.1 Intas Pharma Company Information
- 4.3.2 Intas Pharma Business Overview
- 4.3.3 Intas Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Intas Pharma Epirubicin Hydrochloride Product Portfolio
- 4.3.5 Intas Pharma Recent Developments
- 4.4 Microbiopharm Japan
- 4.4.1 Microbiopharm Japan Company Information
- 4.4.2 Microbiopharm Japan Business Overview
- 4.4.3 Microbiopharm Japan Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Microbiopharm Japan Epirubicin Hydrochloride Product Portfolio
- 4.4.5 Microbiopharm Japan Recent Developments
- 4.5 Sterling Biotech
- 4.5.1 Sterling Biotech Company Information
- 4.5.2 Sterling Biotech Business Overview
- 4.5.3 Sterling Biotech Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sterling Biotech Epirubicin Hydrochloride Product Portfolio
- 4.5.5 Sterling Biotech Recent Developments
- 4.6 Synbias Pharma
- 4.6.1 Synbias Pharma Company Information
- 4.6.2 Synbias Pharma Business Overview
- 4.6.3 Synbias Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Synbias Pharma Epirubicin Hydrochloride Product Portfolio
- 4.6.5 Synbias Pharma Recent Developments
- 4.7 Teva API
- 4.7.1 Teva API Company Information
- 4.7.2 Teva API Business Overview
- 4.7.3 Teva API Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Teva API Epirubicin Hydrochloride Product Portfolio
- 4.7.5 Teva API Recent Developments
- 4.8 Beijing Union Pharmaceutical Factory
- 4.8.1 Beijing Union Pharmaceutical Factory Company Information
- 4.8.2 Beijing Union Pharmaceutical Factory Business Overview
- 4.8.3 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Product Portfolio
- 4.8.5 Beijing Union Pharmaceutical Factory Recent Developments
- 4.9 DZD Heze Pharma
- 4.9.1 DZD Heze Pharma Company Information
- 4.9.2 DZD Heze Pharma Business Overview
- 4.9.3 DZD Heze Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 DZD Heze Pharma Epirubicin Hydrochloride Product Portfolio
- 4.9.5 DZD Heze Pharma Recent Developments
- 4.10 Pfizer
- 4.10.1 Pfizer Company Information
- 4.10.2 Pfizer Business Overview
- 4.10.3 Pfizer Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Epirubicin Hydrochloride Product Portfolio
- 4.10.5 Pfizer Recent Developments
- 4.11 Lunan Pharmaceutical Group
- 4.11.1 Lunan Pharmaceutical Group Company Information
- 4.11.2 Lunan Pharmaceutical Group Business Overview
- 4.11.3 Lunan Pharmaceutical Group Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Lunan Pharmaceutical Group Epirubicin Hydrochloride Product Portfolio
- 4.11.5 Lunan Pharmaceutical Group Recent Developments
- 4.12 Zhejiang Hisun Pharma
- 4.12.1 Zhejiang Hisun Pharma Company Information
- 4.12.2 Zhejiang Hisun Pharma Business Overview
- 4.12.3 Zhejiang Hisun Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Zhejiang Hisun Pharma Epirubicin Hydrochloride Product Portfolio
- 4.12.5 Zhejiang Hisun Pharma Recent Developments
5 Global Epirubicin Hydrochloride Market Scenario by Region
- 5.1 Global Epirubicin Hydrochloride Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Epirubicin Hydrochloride Sales by Region: 2021-2032
- 5.2.1 Global Epirubicin Hydrochloride Sales by Region: 2021-2026
- 5.2.2 Global Epirubicin Hydrochloride Sales by Region: 2027-2032
- 5.3 Global Epirubicin Hydrochloride Revenue by Region: 2021-2032
- 5.3.1 Global Epirubicin Hydrochloride Revenue by Region: 2021-2026
- 5.3.2 Global Epirubicin Hydrochloride Revenue by Region: 2027-2032
- 5.4 North America Epirubicin Hydrochloride Market Facts & Figures by Country
- 5.4.1 North America Epirubicin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Epirubicin Hydrochloride Sales by Country (2021-2032)
- 5.4.3 North America Epirubicin Hydrochloride Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Epirubicin Hydrochloride Market Facts & Figures by Country
- 5.5.1 Europe Epirubicin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Epirubicin Hydrochloride Sales by Country (2021-2032)
- 5.5.3 Europe Epirubicin Hydrochloride Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Epirubicin Hydrochloride Market Facts & Figures by Country
- 5.6.1 Asia Pacific Epirubicin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Epirubicin Hydrochloride Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Epirubicin Hydrochloride Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Epirubicin Hydrochloride Market Facts & Figures by Country
- 5.7.1 South America Epirubicin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Epirubicin Hydrochloride Sales by Country (2021-2032)
- 5.7.3 South America Epirubicin Hydrochloride Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Epirubicin Hydrochloride Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Epirubicin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Epirubicin Hydrochloride Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Epirubicin Hydrochloride Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Epirubicin Hydrochloride Sales by Type (2021-2032)
- 6.1.1 Global Epirubicin Hydrochloride Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Epirubicin Hydrochloride Sales Market Share by Type (2021-2032)
- 6.2 Global Epirubicin Hydrochloride Revenue by Type (2021-2032)
- 6.2.1 Global Epirubicin Hydrochloride Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Epirubicin Hydrochloride Revenue Market Share by Type (2021-2032)
- 6.3 Global Epirubicin Hydrochloride Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Epirubicin Hydrochloride Sales by Application (2021-2032)
- 7.1.1 Global Epirubicin Hydrochloride Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Epirubicin Hydrochloride Sales Market Share by Application (2021-2032)
- 7.2 Global Epirubicin Hydrochloride Revenue by Application (2021-2032)
- 7.2.1 Global Epirubicin Hydrochloride Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Epirubicin Hydrochloride Revenue Market Share by Application (2021-2032)
- 7.3 Global Epirubicin Hydrochloride Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Epirubicin Hydrochloride Value Chain Analysis
- 8.1.1 Epirubicin Hydrochloride Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Epirubicin Hydrochloride Production Mode & Process
- 8.2 Epirubicin Hydrochloride Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Epirubicin Hydrochloride Distributors
- 8.2.3 Epirubicin Hydrochloride Customers
9 Global Epirubicin Hydrochloride Analyzing Market Dynamics
- 9.1 Epirubicin Hydrochloride Industry Trends
- 9.2 Epirubicin Hydrochloride Industry Drivers
- 9.3 Epirubicin Hydrochloride Industry Opportunities and Challenges
- 9.4 Epirubicin Hydrochloride Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst